[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100461959":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":22,"centralContacts":23,"locations":29,"responsibleParty":204,"collaborators":22,"id":206,"slug":207,"hasResults":208,"nctId":209,"briefTitle":210,"officialTitle":211,"acronym":22,"eligibilityCriteria":212,"healthyVolunteers":208,"sex":213,"minAge":214,"maxAge":22,"enrollmentInfo":215,"targetDuration":22,"studyType":218,"phases":219,"briefSummary":222,"conditions":223,"keywords":225,"overallStatus":32,"whyStopped":22,"lastUpdateSubmitDate":233,"lastUpdatePostDateStruct":234,"startDateStruct":237,"completionDateStruct":239,"leadSponsor":241,"locationsCount":242},{"fullName":5,"class":6},"ModernaTX, Inc.","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"mRNA-3705","EXPERIMENTAL","Participants will receive mRNA-3705 at the same dose levels at the same dosing interval (every 2 weeks \\[Q2W\\], or every 3 weeks \\[Q3W\\]) last received in the clinical study of mRNA-3705 in which they initially participated, unless the Sponsor recommends modification.",[13],"Drug: mRNA-3705",[15],{"type":16,"name":9,"description":17,"armGroupLabels":18,"otherNames":19},"DRUG","A sterile liquid for injection",[9],[20,21],"modified mRNA encoding human","methylmalonyl-coenzyme A mutase",null,[24],{"name":25,"role":26,"phone":27,"phoneExt":22,"email":28},"Moderna WeCare Team","CONTACT","1-866-663-3762","WeCareClinicalTrials@modernatx.com",[30,48,61,74,90,104,119,136,150,166,179,191],{"facility":31,"status":32,"city":33,"state":34,"zip":35,"country":36,"countryCode":37,"cosmosGeoPoint":38,"geoPoint":43,"contacts":44},"UCLA Medical Center","RECRUITING","Los Angeles","California","90095","United States","US",{"type":39,"coordinates":40},"Point",[41,42],-118.24368,34.05223,{"lat":42,"lon":41},[45],{"name":46,"role":26,"phone":22,"phoneExt":22,"email":47},"Monserrath Campos","monserrathcampos@mednet.ucla.edu",{"facility":49,"status":32,"city":50,"state":34,"zip":51,"country":36,"countryCode":37,"cosmosGeoPoint":52,"geoPoint":56,"contacts":57},"Lucile Packard Children's Hospital at Stanford","Palo Alto","94304",{"type":39,"coordinates":53},[54,55],-122.14302,37.44188,{"lat":55,"lon":54},[58],{"name":59,"role":26,"phone":22,"phoneExt":22,"email":60},"Thu Quan","tquan@stanford.edu",{"facility":62,"status":32,"city":63,"state":34,"zip":64,"country":36,"countryCode":37,"cosmosGeoPoint":65,"geoPoint":69,"contacts":70},"Altman Clinical and Translational Research Institution","San Diego","92037",{"type":39,"coordinates":66},[67,68],-117.16472,32.71571,{"lat":68,"lon":67},[71],{"name":72,"role":26,"phone":22,"phoneExt":22,"email":73},"Nicolle Mendez","n3mendez@health.ucsd.edu",{"facility":75,"status":32,"city":76,"state":77,"zip":78,"country":79,"countryCode":80,"cosmosGeoPoint":81,"geoPoint":85,"contacts":86},"Stollery Children's Hospital University of Alberta","Edmonton","Alberta","T6G 2R7","Canada","CA",{"type":39,"coordinates":82},[83,84],-113.46871,53.55014,{"lat":84,"lon":83},[87],{"name":88,"role":26,"phone":22,"phoneExt":22,"email":89},"Cheri Copithorne","cheri.robert@ahs.ca",{"facility":91,"status":32,"city":92,"state":93,"zip":94,"country":79,"countryCode":80,"cosmosGeoPoint":95,"geoPoint":99,"contacts":100},"Hospital For Sick Children","Toronto","Ontario","M5G 1X8",{"type":39,"coordinates":96},[97,98],-79.39864,43.70643,{"lat":98,"lon":97},[101],{"name":102,"role":26,"phone":22,"phoneExt":22,"email":103},"Preet Dhillon","preet.dhillon@sickkids.ca",{"facility":105,"status":32,"city":106,"state":22,"zip":107,"country":108,"countryCode":109,"cosmosGeoPoint":110,"geoPoint":114,"contacts":115},"Hôpital Necker - Enfants Malades APHP","Paris","75015","France","FR",{"type":39,"coordinates":111},[112,113],2.3488,48.85341,{"lat":113,"lon":112},[116],{"name":117,"role":26,"phone":22,"phoneExt":22,"email":118},"Michaela Semeraro","michaela.semeraro@aphp.fr",{"facility":120,"status":32,"city":121,"state":22,"zip":122,"country":123,"countryCode":124,"cosmosGeoPoint":125,"geoPoint":129,"contacts":130},"Erasmus MC","Rotterdam","3015 AA","Netherlands","NL",{"type":39,"coordinates":126},[127,128],4.47917,51.9225,{"lat":128,"lon":127},[131,133],{"name":22,"role":26,"phone":22,"phoneExt":22,"email":132},"m.wagenmakers@erasmusmc.nl",{"name":134,"role":135,"phone":22,"phoneExt":22,"email":22},"Margreet Wagenmakers","PRINCIPAL_INVESTIGATOR",{"facility":137,"status":32,"city":138,"state":22,"zip":139,"country":123,"countryCode":124,"cosmosGeoPoint":140,"geoPoint":144,"contacts":145},"Universitair Medisch Centrum Utrecht","Utrecht","3584 CX",{"type":39,"coordinates":141},[142,143],5.12222,52.09083,{"lat":143,"lon":142},[146,148],{"name":22,"role":26,"phone":22,"phoneExt":22,"email":147},"s.michel-2@umcutrecht.nl",{"name":149,"role":135,"phone":22,"phoneExt":22,"email":22},"Sabine Fuchs",{"facility":151,"status":32,"city":152,"state":153,"zip":154,"country":155,"countryCode":156,"cosmosGeoPoint":157,"geoPoint":161,"contacts":162},"Hospital Universitario Cruces","Barakaldo","Vizcaya","48903","Spain","ES",{"type":39,"coordinates":158},[159,160],-2.98813,43.29639,{"lat":160,"lon":159},[163],{"name":164,"role":26,"phone":22,"phoneExt":22,"email":165},"Ohiane Martin Rodriguez","ohiane.martinrodriguez@bio-bizkaia.eus",{"facility":167,"status":32,"city":168,"state":22,"zip":169,"country":155,"countryCode":156,"cosmosGeoPoint":170,"geoPoint":174,"contacts":175},"Hospital Universitario 12 de Octubre","Madrid","28041",{"type":39,"coordinates":171},[172,173],-3.70256,40.4165,{"lat":173,"lon":172},[176],{"name":177,"role":26,"phone":22,"phoneExt":22,"email":178},"Ianire Gallego Amaro","ianireupic@gmail.com",{"facility":180,"status":181,"city":182,"state":22,"zip":183,"country":184,"countryCode":185,"cosmosGeoPoint":186,"geoPoint":190,"contacts":22},"Birmingham Children's Hospital NHS Foundation Trust","TERMINATED","Birmingham","B4 6NH","United Kingdom","UK",{"type":39,"coordinates":187},[188,189],-1.89983,52.48142,{"lat":189,"lon":188},{"facility":192,"status":32,"city":193,"state":22,"zip":194,"country":184,"countryCode":185,"cosmosGeoPoint":195,"geoPoint":199,"contacts":200},"Royal Manchester Childrens Hospital","Manchester","M13 9WL",{"type":39,"coordinates":196},[197,198],-2.23743,53.48095,{"lat":198,"lon":197},[201],{"name":202,"role":26,"phone":22,"phoneExt":22,"email":203},"Laura Crowther","genetics.research@mft.nhs.uk",{"type":205,"investigatorFullName":22,"investigatorTitle":22,"investigatorAffiliation":22,"oldNameTitle":22,"oldOrganization":22},"SPONSOR","100461959","phase-1-an-extension-study-to-evaluate-the-long-term-safety-and-clinical-activity-of-mrna-3705-in-participants-previously-enrolled-in-other-clinical-studies-of-mrna-3705-100461959",false,"NCT05295433","An Extension Study to Evaluate the Long-Term Safety and Clinical Activity of mRNA-3705 in Participants Previously Enrolled in Other Clinical Studies of mRNA-3705","A Phase 1\u002F2, Global, Open-Label, Extension Study to Evaluate the Long-Term Safety and Clinical Activity of mRNA-3705 in Participants Previously Enrolled in Other Clinical Studies of mRNA-3705","Inclusion Criteria:\n\n* Completed the assigned dose regimen treatment time period in other clinical studies of mRNA-3705 or is eligible for early transition to this study because they missed more than 3 consecutive doses of study drug due to coronavirus disease 2019 (COVID-19) vaccination during Study mRNA-3705-P101 Part 1.\n* Completed the End of treatment (EOT) Visit (or End of Study Visit in the case of unscheduled dosing) in Study mRNA-3705-P101 within 10 days of their first dose of mRNA-3705 in this extension study.\n\nExclusion Criteria:\n\n* Not expected to receive clinical benefit from continued mRNA-3705 administration, in the opinion of the Investigator.\n* Any clinical or laboratory abnormality or medical condition that, at the discretion of the Investigator, may put the individual at increased risk by participating in this study.\n* History of liver and\u002For kidney transplant.\n\nNOTE: Other inclusion and exclusion criteria may apply.","ALL","1 Year",{"count":216,"type":217},56,"ESTIMATED","INTERVENTIONAL",[220,221],"PHASE1","PHASE2","The primary objective of this study is to evaluate the long-term safety and clinical activity of mRNA-3705 administered to participants with isolated methylmalonic acidemia (MMA) due to methylmalonyl-coenzyme A mutase (MUT) deficiency who have previously participated in other clinical studies of mRNA-3705.",[224],"Methylmalonic Acidemia",[226,227,228,229,230,231,232,9],"Isolated Methylmalonic acidemia","Isolated methylmalonic aciduria","Elevated methylmalonic acid (MMA)","Metabolism, Inborn Errors","Genetic Diseases","Moderna","mRNA","2025-12-22",{"date":235,"type":236},"2025-12-23","ACTUAL",{"date":238,"type":236},"2022-03-08",{"date":240,"type":217},"2034-04-02",{"name":5,"class":6},12]